TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

36.50$ -0.6% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios TEVA
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
26.0
2.1
4.6
2.9
15.9
31.9
3.1%
Margins
42.3% 43.7% 43.0% 45.5% 45.0% 40.8% 43.5% 46.4% 46.7% 47.2% 50.7% 51.8% 53.8% 53.0% 56.2% 52.0% 52.4% 52.7% 54.5% 57.8% 54.1% 48.4% 44.0% 44.6% 46.4% 47.8% 46.7% 48.2% 48.7% 51.8%
13.6% 15.6% 13.0% 15.5% 14.0% 17.4% 20.8% 26.8% 12.0% 25.0% 9.5% 25.5% 10.3% 17.3% 24.0% 17.0% 10.9% 8.1% 19.5% 17.1% 9.8% -78.1% -8.7% -2.6% -21.4% 10.8% -14.7% 2.7% -1.8% 12.5%
7.7% 9.1% 6.2% 9.2% 8.5% 13.4% 16.3% 21.1% 6.9% 20.4% 6.5% 20.7% 5.7% 14.4% 20.7% 15.1% 9.7% 6.2% 15.1% 8.1% 1.5% -72.7% -11.4% -5.9% -24.0% 2.6% -16.4% -3.5% -9.9% 8.2%
-14.9% 11.7% -5.9% 6.7% 4.4% 6.7% 7.7% 12.8% 19.5% 20.2% 19.8% 13.5% 23.0% 19.1% 21.3% 16.8% 17.1% 10.9% 20.7% 24.3% 19.7% 11.8% 9.5% 2.5% 3.8% 1.5% 7.0% 5.3% 4.5% 6.7%
Returns
13.7% 16.6% 10.4% 15.9% 12.9% 20.2% 22.4% 21.0% 6.2% 17.7% 4.9% 14.2% 3.9% 10.4% 15.2% 12.4% 8.6% 5.6% 13.1% 5.3% 1.0% -93.7% -14.6% -7.2% -39.8% 4.1% -31.3% -7.4% -30.5% 17.8%
5.9% 8.5% 4.8% 6.9% 5.2% 8.0% 8.9% 11.7% 3.4% 10.3% 2.7% 8.3% 1.9% 5.9% 8.5% 5.5% 3.9% 2.7% 6.6% 2.9% 0.4% -23.0% -3.5% -1.7% -7.9% 0.9% -5.6% -1.3% -4.2% 3.5%
Balance Sheet & Debt
280 189 277 199 735 684 1,090 402 1,504 873 3,995 3,700 6,589 3,617 4,294 13,420 11,839 11,153 8,101 2,986 34,812 31,512 27,134 24,932 23,742 20,878 18,411 16,607 14,483 13,250
1.6 0.8 1.1 0.6 1.6 1.4 2.1 0.4 1.1 0.6 1.6 1.5 4.0 1.5 0.9 3.2 3.0 3.5 1.4 0.5 12.1 145.9 5.6 5.1 4.7 38.4 3.3 4.2
43.0% 51.5% 45.9% 43.3% 40.3% 39.9% 39.5% 55.6% 55.9% 58.2% 54.4% 58.6% 49.5% 56.9% 56.2% 44.3% 45.0% 47.5% 50.2% 54.9% 35.9% 24.6% 24.2% 24.3% 19.8% 21.6% 17.7% 17.3% 13.7% 19.4%
0.6 0.4 0.5 0.4 1.0 1.1 1.0 0.4 0.4 0.4 0.5 0.4 0.5 0.3 0.3 0.7 0.6 0.5 0.4 0.3 1.1 1.9 2.0 1.9 2.6 2.2 2.7 2.6 3.3 2.1
Per Share
0.15 0.21 0.14 0.24 0.28 0.51 0.73 1.17 0.48 1.57 0.68 2.35 0.77 2.23 3.62 3.09 2.25 1.49 3.56 1.84 0.34 -16.01 -2.11 -0.92 -3.64 0.38 -2.20 -0.50 -1.45 1.20
1.95 2.28 2.29 2.61 3.36 3.81 4.48 5.55 6.98 7.71 10.44 11.33 13.52 15.51 17.50 20.51 23.27 23.90 23.63 22.75 22.79 22.03 18.47 15.48 15.21 14.34 13.45 14.16 14.63 14.71
1.09 1.25 1.35 1.51 2.21 2.53 3.26 5.58 7.83 8.87 13.84 16.53 19.88 21.45 23.83 24.85 26.08 26.55 27.17 34.45 34.69 17.09 14.40 12.81 9.16 9.28 7.03 6.71 4.75 6.74
-0.29 0.27 -0.13 0.18 0.15 0.25 0.34 0.71 1.36 1.56 2.07 1.53 3.11 2.96 3.72 3.45 3.97 2.60 4.89 5.52 4.50 2.59 1.76 0.38 0.58 0.21 0.94 0.75 0.66 0.98

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?